Ciclosporin A (CyA) was the cornerstone of rescue medical therapy for steroid-refractory acute severe colitis until the advent of anti-TNF agents. CyA is a competitive calcinuerin inhibitor with ...
Remicade trough levels 2 weeks after infusion were significantly lower in patients with acute severe ulcerative colitis vs. patients with moderately severe ulcerative colitis, according to the results ...
The Lindgren score was better than three other currently available scores at predicting major clinical outcomes in patients with acute severe ulcerative colitis, according to research published in ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Hospitalized ...
AZoLifeSciences on MSN
Engineered Gut Bacteria With MiRNA Nanoparticles To Reverse IBD
Biomimetic nanoparticles delivering microRNA to gut bacteria enhance protective metabolites, repair intestinal barriers, and ...
Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic relapsing-remitting diseases of the gastrointestinal tract 1. Patients present with (bloody) ...
Although acute severe ulcerative colitis (ASUC) is recognized as a life-threatening flare associated with elevated thrombotic risk, the extent and duration of hypercoagulability after hospital ...
This is a preview. Log in through your library . Abstract Patients with inflammatory bowel disease (IBD) have increased numbers of human tryptase-β (hTryptase-β)-positive mast cells (MCs) in the ...
Although the majority of patients with chronic UC never require admission to the hospital and can be managed successfully with oral medications, approximately 15% of UC patients will require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback